Table 1.

Overview of Published Literature Identifying Clostridioides difficile Infection Health Disparities

StudyPopulationOutcomeKey FindingsP Value
Freedberg et al 2013Single-center hospital
(n = 894 CDI patients)
CDI recurrenceBlack versus White race
Hazard ratio, 1.66; 95% confidence interval, 1.05–2.63
Mao et al 2015National sample of US hospital discharges that included antibiotic exposure (n = 178 000 CDI discharges)CDI incidenceBlack race: 0.75%
Asian race: 0.25%
Hispanic ethnicity: 0.50%
White race: 1.0%;
.001
.003
.059
.001
CDI complicationsBlack race: 7.8%
Asian race: 9.0%
Hispanic ethnicity: 7.8%
White race: 8.25%
1.000
.824
.824
1.000
Inpatient mortalityBlack race: 1.0%
Asian race: 0.20%
Hispanic ethnicity: 1.5%
White race: 1.2%
1.000
Argamany et al 2016National sample of US hospital discharges (n = 1.7 million CDI discharges)CDI incidenceBlack race: 4.9 per 1000
White race: 7.7 per 1000
<.001
Severe CDIBlack race: 24%
White race: 19%
<.001
Inpatient mortalityBlack race: 7.4%
White race: 7.2%
<.001
LOS >7 daysBlack race: 57%
White race: 52%
<.001
Young et al 2022National sample of US healthcare system (n = 45 331 CDI encounters)Severe CDIBlack race: aOR 1.85 (1.71–2.00)
Hispanic ethnicity: aOR 1.22 (1.08–1.38)
Recurrent CDIBlack race: aOR 1.17 (1.03–1.34)
Hispanic ethnicity: aOR 0.94 (0.76–1.17)
Inpatient mortalityBlack race: aOR 0.96 (0.82–1.13)
Hispanic ethnicity: aOR 0.93 (0.72–1.21)
LOS >7 daysBlack race: aOR 1.29 (1.19–1.41)
Hispanic ethnicity: aOR 0.89 (0.78–1.02)
Treatment costs (recurrent CDI)Black race: $12 352,
Hispanic ethnicity: $11 019
White race: $8502
<.001 < .001
Lee et al 2023Single hospital system (n = 219 CDI patients)Severe CDIREM: 40.0%
Non-REM: 38.1%
.779
Intensive care unit admissionREM: 42.2%
Non-REM: 26.2%,
.016
Inpatient mortalityREM: 10.4%
Non-REM: 13.1%,
.537
LOS >10 daysREM: 74.0%
Non-REM: 32.0%
.016
Skrobarcek et al 2021CDI surveillance in 10 US states (n = 9413 CA-CDI cases)“Poverty” factorRR: 1.19 (1.15–1.22).0001
“Foreign-born” factorRR: 1.05 (1.02–1.08)<.001
“High-income” factorRR: 0.95 (0.92–0.97)<.001
Hudspeth et al 2019CDI surveillance in Bernalillo County, New Mexico (n = 1672 CA-CDI cases)>20% no health insuranceIncidence rate ratio: 1.718 (1.4–2.108)<.001
CDI incidenceWhite women: Reference
Black women: 5.98 (3.379–10.567)
Asian race: 9.353 (5.444–16.067)
White men: Reference
Black men: 27.681 (12.931–59.256)
American Indian/Alaskan Native men: 11.657 (5.781–23.507)
<.001
<.001
<.001
<.001
StudyPopulationOutcomeKey FindingsP Value
Freedberg et al 2013Single-center hospital
(n = 894 CDI patients)
CDI recurrenceBlack versus White race
Hazard ratio, 1.66; 95% confidence interval, 1.05–2.63
Mao et al 2015National sample of US hospital discharges that included antibiotic exposure (n = 178 000 CDI discharges)CDI incidenceBlack race: 0.75%
Asian race: 0.25%
Hispanic ethnicity: 0.50%
White race: 1.0%;
.001
.003
.059
.001
CDI complicationsBlack race: 7.8%
Asian race: 9.0%
Hispanic ethnicity: 7.8%
White race: 8.25%
1.000
.824
.824
1.000
Inpatient mortalityBlack race: 1.0%
Asian race: 0.20%
Hispanic ethnicity: 1.5%
White race: 1.2%
1.000
Argamany et al 2016National sample of US hospital discharges (n = 1.7 million CDI discharges)CDI incidenceBlack race: 4.9 per 1000
White race: 7.7 per 1000
<.001
Severe CDIBlack race: 24%
White race: 19%
<.001
Inpatient mortalityBlack race: 7.4%
White race: 7.2%
<.001
LOS >7 daysBlack race: 57%
White race: 52%
<.001
Young et al 2022National sample of US healthcare system (n = 45 331 CDI encounters)Severe CDIBlack race: aOR 1.85 (1.71–2.00)
Hispanic ethnicity: aOR 1.22 (1.08–1.38)
Recurrent CDIBlack race: aOR 1.17 (1.03–1.34)
Hispanic ethnicity: aOR 0.94 (0.76–1.17)
Inpatient mortalityBlack race: aOR 0.96 (0.82–1.13)
Hispanic ethnicity: aOR 0.93 (0.72–1.21)
LOS >7 daysBlack race: aOR 1.29 (1.19–1.41)
Hispanic ethnicity: aOR 0.89 (0.78–1.02)
Treatment costs (recurrent CDI)Black race: $12 352,
Hispanic ethnicity: $11 019
White race: $8502
<.001 < .001
Lee et al 2023Single hospital system (n = 219 CDI patients)Severe CDIREM: 40.0%
Non-REM: 38.1%
.779
Intensive care unit admissionREM: 42.2%
Non-REM: 26.2%,
.016
Inpatient mortalityREM: 10.4%
Non-REM: 13.1%,
.537
LOS >10 daysREM: 74.0%
Non-REM: 32.0%
.016
Skrobarcek et al 2021CDI surveillance in 10 US states (n = 9413 CA-CDI cases)“Poverty” factorRR: 1.19 (1.15–1.22).0001
“Foreign-born” factorRR: 1.05 (1.02–1.08)<.001
“High-income” factorRR: 0.95 (0.92–0.97)<.001
Hudspeth et al 2019CDI surveillance in Bernalillo County, New Mexico (n = 1672 CA-CDI cases)>20% no health insuranceIncidence rate ratio: 1.718 (1.4–2.108)<.001
CDI incidenceWhite women: Reference
Black women: 5.98 (3.379–10.567)
Asian race: 9.353 (5.444–16.067)
White men: Reference
Black men: 27.681 (12.931–59.256)
American Indian/Alaskan Native men: 11.657 (5.781–23.507)
<.001
<.001
<.001
<.001

Abbreviations: aOR, adjusted odds ratio; CA-CDI, community-associated Clostridioides difficile infection; CDI, Clostridioides difficile infection; LOS, hospital length of stay; REM, persons from racial or ethnic minority groups; RR, relative risk.

Table 1.

Overview of Published Literature Identifying Clostridioides difficile Infection Health Disparities

StudyPopulationOutcomeKey FindingsP Value
Freedberg et al 2013Single-center hospital
(n = 894 CDI patients)
CDI recurrenceBlack versus White race
Hazard ratio, 1.66; 95% confidence interval, 1.05–2.63
Mao et al 2015National sample of US hospital discharges that included antibiotic exposure (n = 178 000 CDI discharges)CDI incidenceBlack race: 0.75%
Asian race: 0.25%
Hispanic ethnicity: 0.50%
White race: 1.0%;
.001
.003
.059
.001
CDI complicationsBlack race: 7.8%
Asian race: 9.0%
Hispanic ethnicity: 7.8%
White race: 8.25%
1.000
.824
.824
1.000
Inpatient mortalityBlack race: 1.0%
Asian race: 0.20%
Hispanic ethnicity: 1.5%
White race: 1.2%
1.000
Argamany et al 2016National sample of US hospital discharges (n = 1.7 million CDI discharges)CDI incidenceBlack race: 4.9 per 1000
White race: 7.7 per 1000
<.001
Severe CDIBlack race: 24%
White race: 19%
<.001
Inpatient mortalityBlack race: 7.4%
White race: 7.2%
<.001
LOS >7 daysBlack race: 57%
White race: 52%
<.001
Young et al 2022National sample of US healthcare system (n = 45 331 CDI encounters)Severe CDIBlack race: aOR 1.85 (1.71–2.00)
Hispanic ethnicity: aOR 1.22 (1.08–1.38)
Recurrent CDIBlack race: aOR 1.17 (1.03–1.34)
Hispanic ethnicity: aOR 0.94 (0.76–1.17)
Inpatient mortalityBlack race: aOR 0.96 (0.82–1.13)
Hispanic ethnicity: aOR 0.93 (0.72–1.21)
LOS >7 daysBlack race: aOR 1.29 (1.19–1.41)
Hispanic ethnicity: aOR 0.89 (0.78–1.02)
Treatment costs (recurrent CDI)Black race: $12 352,
Hispanic ethnicity: $11 019
White race: $8502
<.001 < .001
Lee et al 2023Single hospital system (n = 219 CDI patients)Severe CDIREM: 40.0%
Non-REM: 38.1%
.779
Intensive care unit admissionREM: 42.2%
Non-REM: 26.2%,
.016
Inpatient mortalityREM: 10.4%
Non-REM: 13.1%,
.537
LOS >10 daysREM: 74.0%
Non-REM: 32.0%
.016
Skrobarcek et al 2021CDI surveillance in 10 US states (n = 9413 CA-CDI cases)“Poverty” factorRR: 1.19 (1.15–1.22).0001
“Foreign-born” factorRR: 1.05 (1.02–1.08)<.001
“High-income” factorRR: 0.95 (0.92–0.97)<.001
Hudspeth et al 2019CDI surveillance in Bernalillo County, New Mexico (n = 1672 CA-CDI cases)>20% no health insuranceIncidence rate ratio: 1.718 (1.4–2.108)<.001
CDI incidenceWhite women: Reference
Black women: 5.98 (3.379–10.567)
Asian race: 9.353 (5.444–16.067)
White men: Reference
Black men: 27.681 (12.931–59.256)
American Indian/Alaskan Native men: 11.657 (5.781–23.507)
<.001
<.001
<.001
<.001
StudyPopulationOutcomeKey FindingsP Value
Freedberg et al 2013Single-center hospital
(n = 894 CDI patients)
CDI recurrenceBlack versus White race
Hazard ratio, 1.66; 95% confidence interval, 1.05–2.63
Mao et al 2015National sample of US hospital discharges that included antibiotic exposure (n = 178 000 CDI discharges)CDI incidenceBlack race: 0.75%
Asian race: 0.25%
Hispanic ethnicity: 0.50%
White race: 1.0%;
.001
.003
.059
.001
CDI complicationsBlack race: 7.8%
Asian race: 9.0%
Hispanic ethnicity: 7.8%
White race: 8.25%
1.000
.824
.824
1.000
Inpatient mortalityBlack race: 1.0%
Asian race: 0.20%
Hispanic ethnicity: 1.5%
White race: 1.2%
1.000
Argamany et al 2016National sample of US hospital discharges (n = 1.7 million CDI discharges)CDI incidenceBlack race: 4.9 per 1000
White race: 7.7 per 1000
<.001
Severe CDIBlack race: 24%
White race: 19%
<.001
Inpatient mortalityBlack race: 7.4%
White race: 7.2%
<.001
LOS >7 daysBlack race: 57%
White race: 52%
<.001
Young et al 2022National sample of US healthcare system (n = 45 331 CDI encounters)Severe CDIBlack race: aOR 1.85 (1.71–2.00)
Hispanic ethnicity: aOR 1.22 (1.08–1.38)
Recurrent CDIBlack race: aOR 1.17 (1.03–1.34)
Hispanic ethnicity: aOR 0.94 (0.76–1.17)
Inpatient mortalityBlack race: aOR 0.96 (0.82–1.13)
Hispanic ethnicity: aOR 0.93 (0.72–1.21)
LOS >7 daysBlack race: aOR 1.29 (1.19–1.41)
Hispanic ethnicity: aOR 0.89 (0.78–1.02)
Treatment costs (recurrent CDI)Black race: $12 352,
Hispanic ethnicity: $11 019
White race: $8502
<.001 < .001
Lee et al 2023Single hospital system (n = 219 CDI patients)Severe CDIREM: 40.0%
Non-REM: 38.1%
.779
Intensive care unit admissionREM: 42.2%
Non-REM: 26.2%,
.016
Inpatient mortalityREM: 10.4%
Non-REM: 13.1%,
.537
LOS >10 daysREM: 74.0%
Non-REM: 32.0%
.016
Skrobarcek et al 2021CDI surveillance in 10 US states (n = 9413 CA-CDI cases)“Poverty” factorRR: 1.19 (1.15–1.22).0001
“Foreign-born” factorRR: 1.05 (1.02–1.08)<.001
“High-income” factorRR: 0.95 (0.92–0.97)<.001
Hudspeth et al 2019CDI surveillance in Bernalillo County, New Mexico (n = 1672 CA-CDI cases)>20% no health insuranceIncidence rate ratio: 1.718 (1.4–2.108)<.001
CDI incidenceWhite women: Reference
Black women: 5.98 (3.379–10.567)
Asian race: 9.353 (5.444–16.067)
White men: Reference
Black men: 27.681 (12.931–59.256)
American Indian/Alaskan Native men: 11.657 (5.781–23.507)
<.001
<.001
<.001
<.001

Abbreviations: aOR, adjusted odds ratio; CA-CDI, community-associated Clostridioides difficile infection; CDI, Clostridioides difficile infection; LOS, hospital length of stay; REM, persons from racial or ethnic minority groups; RR, relative risk.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close